While overall and admission cardiogenic shock mortality rates in AMI have declined in South Korea, delayed cardiogenic shock mortality has not, highlighting a need for improved early identification and alternative therapies.
The decline in mortality rates of overall and ba-CS but not that of da-CS emphasizes the need for enhanced prevention strategies, early identification of development of CS after admission, and alternative therapeutic strategies for patients at high risk of CS in the acute stage of AMI.
Song et al. (Thu,) studied this question.